Roberto Pili, MD
State University of New York at Buffalo · Indiana University School of Medicine, Indiana University Simon Cancer Center · Indiana Univervisty Simon Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Roberto Pili, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:23 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06222593 · Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCCState University of New York at Buffalo · recruiting · Carcinoma, Renal Cell · principal investigator
- N/ANCT04960956 · Glycosylation of Exosomes in Prostate and Urothelial CarcinomaIndiana University · terminated · Prostate Cancer, Urothelial Carcinoma · principal investigator
- Ph2NCT03552380 · Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell CarcinomaRoberto Pili · terminated · Renal Cell Carcinoma · principal investigator
- Ph2NCT03501381 · High Dose IL 2 and Entinostat in RCCRoberto Pili · active not recruiting · Renal Cell Carcinoma · principal investigator
- Ph1NCT02619253 · Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell CarcinomaNabil Adra · completed · Renal Cell Carcinoma, Urinary Bladder Neoplasms · principal investigator
- Ph2NCT00560482 · Efficacy Study of ABR-215050 to Treat Prostate CancerActive Biotech AB · completed · Prostate Cancer · principal investigator
- Ph2NCT00111618 · Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate CancerAntisoma Research · completed · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.